Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Drug Metabolism and Pharmacokinetics
|
November 30, 2015
Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhaler
Sebastian Frechen, Ahmed Abbas Suleiman, Ali Mohammad Nejad Sigaroudi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 4, 2025
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat
Paul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 10, 2018
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin
Nina Hanke, Sebastian Frechen, Daniel Moj, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 12, 2025
Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 1: in vitro modeling of Vericiguat
Paul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
The Journal of Antimicrobial Chemotherapy
|
May 26, 2017
Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens
Max Taubert, Johannes Zander, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 4, 2021
A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions
Sebastian Frechen, Juri Solodenko, Thomas Wendl, et al.
Clinical Pharmacokinetics
|
May 27, 2019
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug-Drug-Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole
Denise Türk, Nina Hanke, Sarah Wolf, et al.
The AAPS Journal
|
November 9, 2016
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens
Daniel Moj, Nina Hanke, Hannah Britz, et al.
Clinical Pharmacology and Therapeutics
|
December 18, 2023
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling
Friederike Kanefendt, André Dallmann, Huijun Chen, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Predictive Pediatric Modeling and Simulation Using Ontogeny Information
Ibrahim Ince, Juri Solodenko, Sebastian Frechen, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Drug Metabolism and Pharmacokinetics
|
November 30, 2015
Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhaler
Sebastian Frechen, Ahmed Abbas Suleiman, Ali Mohammad Nejad Sigaroudi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 4, 2025
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat
Paul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 10, 2018
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin
Nina Hanke, Sebastian Frechen, Daniel Moj, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 12, 2025
Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 1: in vitro modeling of Vericiguat
Paul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
The Journal of Antimicrobial Chemotherapy
|
May 26, 2017
Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens
Max Taubert, Johannes Zander, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 4, 2021
A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions
Sebastian Frechen, Juri Solodenko, Thomas Wendl, et al.
Clinical Pharmacokinetics
|
May 27, 2019
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug-Drug-Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole
Denise Türk, Nina Hanke, Sarah Wolf, et al.
The AAPS Journal
|
November 9, 2016
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens
Daniel Moj, Nina Hanke, Hannah Britz, et al.
Clinical Pharmacology and Therapeutics
|
December 18, 2023
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling
Friederike Kanefendt, André Dallmann, Huijun Chen, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Predictive Pediatric Modeling and Simulation Using Ontogeny Information
Ibrahim Ince, Juri Solodenko, Sebastian Frechen, et al.
Page
of 5